
Israeli Defense Firm Elbit Sees More Business Coming From Europe
The head of one of Israel's biggest defense firms said Europe sales will keep growing, shrugging off calls for sanctions and trade restrictions over the war in Gaza.
'We see great business potential in Germany, the UK, Romania, Sweden and Denmark,' Bezhalel Machlis, chief executive officer of Elbit Systems, which makes rockets, drones and laser-based aerial defense systems for the Israeli army, told Bloomberg in a phone interview.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the 10 biotech stocks screaming a buy now. On June 17, Piper Sandler reiterated an 'Overweight' rating on the stock with a $145 price target. The bullish stance follows positive discussions with a European specialist on the company's VYKAT XR medication for Prader-Willi syndrome (PWS). A scientist in a laboratory examining a microscope in the pursuit of cell therapy discoveries. Piper Sandler consulted a UK-based pediatric endocrinologist to understand the drug better. The specialist indicated she would prescribe the drug as medication for Prader-Willi syndrome (PWS) to all eligible patients upon approval. Soleno Therapeutics' edge with the drug stems from the fact that other PWS treatments are in the early stages of development. Piper Sandler believes VYKAT XT represents significant potential as the first approved treatment specifically addressing PWS, a condition. The biotech company plans to file a Marketing Authorization Application for VYKAT XR in the second quarter. It's also pursuing regulatory approval in Europe as it plans to fill with the European Medicines agency. Following regulatory approvals, Soleno Therapeutics Palms will launch the drug in the first quarter of 2026. Soleno Therapeutics is a biopharmaceutical company that develops and commercializes novel treatments for rare diseases. Their lead product, diazoxide choline extended-release tablets (DCCR), is being developed for Prader-Willi syndrome (PWS), specifically to address hyperphagia (excessive hunger). While we acknowledge the potential of SLNO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
an hour ago
- Bloomberg
Plunging UK Retail Sales Deepen Concern About Broader Slowdown
A dramatic drop in UK retail sales is raising fresh questions about the sustainability of Britain's recent growth spurt and Prime Minister Keir Starmer's plans to use it to restore controversial benefit cuts. The volume of goods sold online and in shops dropped 2.7% in May, the Office for National Statistics said on Friday. Not only was that the sharpest decline since December 2023, it was enough to wipe out the combined gains over the previous four months of the year. Economists had expected retail sales to fall only 0.5% last month.
Yahoo
an hour ago
- Yahoo
This Veteran Trader Thinks Crypto's Next Boom Could Mint 'Generational Wealth' — Even as Global Tensions Rise
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The cryptocurrency market rarely operates in isolation from global events, and recent geopolitical tensions have created a complex trading environment that demands careful navigation. According to Fefe, a seasoned educator and trader from Crypto Banter, the current Israel-Iran conflict represents both significant risk and potential opportunity for crypto investors. The recent escalation between Israel and Iran triggered an initial crypto market selloff, but what followed has been more intriguing from a structural perspective. Israel's strategic attacks on Iranian infrastructure, combined with Iran's official statements hinting at nuclear weapon deployment, have introduced unprecedented complexity to market dynamics. Don't Miss: — no wallets, just price speculation and free paper trading to practice different strategies. Grow your IRA or 401(k) with Crypto – . The economic implications extend globally. JPMorgan projects Brent oil prices could spike to $130 per barrel from the current $70–$73 levels in a worst-case scenario, potentially driving U.S. inflation back to 5%. Gold's recent push to all-time highs suggests investors are positioning for prolonged uncertainty, yet crypto's response has shown what Fefe describes as 'seller exhaustion' rather than continued downward pressure. The crypto market's resilience during this stress test reveals important insights. The 'V-shaped recovery' following the initial selloff was notably driven by spot buying rather than leveraged speculation, suggesting underlying strength in the asset class. Fefe's current positioning reflects a calculated approach: Accumulation Strategy: Identifying a 50% retracement level of the recent recovery as an optimal entry point for gradual position building with conservative 3x leverage maximum. Asset Selection: Focusing on Ethereum and Solana , along with their ecosystem plays including DeFi infrastructure, staking protocols like Lido and Aave, and decentralized exchanges. The ETH/SOL focus reflects converging factors beyond technical analysis. Recent Securities and Exchange Commission commentary on self-custody and Web3 technologies suggests policy tailwinds for DeFi ecosystems, while ongoing SOL ETF discussions around staking mechanisms could drive institutional adoption. Trending: New to crypto? on Coinbase. Despite bullish positioning, Fefe emphasizes taking partial profits – 10%-15% – from current positions to avoid 'round-tripping'—giving back gains during volatile periods. This balanced approach maintains exposure to potential upside while protecting against downside surprises. The expectation of diplomatic resolution 'within a week or two' reflects analysis that prolonged conflict serves few stakeholders' interests, particularly given potential oil market disruption and broader economic consequences. Geopolitical events create both risk and opportunity, requiring careful position sizing and risk management in crypto markets Market structure matters: Recent spot-driven buying suggests underlying strength despite surface volatility Selective positioning in established ecosystems such as ETH and SOL, may offer better risk-adjusted returns than broad market exposure Conservative leverage and gradual accumulation help navigate uncertainty while maintaining upside participation Stay informed on both crypto-specific developments and broader macroeconomic catalysts driving market sentiment The current environment exemplifies why successful crypto investing requires understanding not just blockchain technology, but also traditional market dynamics, geopolitical developments, and macroeconomic trends. Should diplomatic progress materialize, crypto markets could benefit from resolution of geopolitical uncertainty, continued institutional adoption, and favorable regulatory developments already in motion. As always, position sizing appropriate to your risk tolerance and maintaining diversification remains fundamental to long-term investment success in these volatile yet potentially rewarding markets. Read Next: A must-have for all crypto enthusiasts: . Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Image: Shutterstock This article This Veteran Trader Thinks Crypto's Next Boom Could Mint 'Generational Wealth' — Even as Global Tensions Rise originally appeared on Sign in to access your portfolio